Literature DB >> 10877167

Hospital-acquired adenovirus 7h infantile respiratory infection in Chile.

M A Palomino1, C Larrañaga, L F Avendaño.   

Abstract

BACKGROUND: Adenoviruses are the second most common cause of viral acute lower respiratory tract infection (ALRI) requiring hospitalization in Chile. Little information is available with respect to nosocomial infection rate by adenovirus. This issue is important because of its potential severity and long term sequelae.
METHODS: Infants hospitalized for ALRI were studied to determine the rate of nosocomial cross-infection with respiratory adenovirus and its corresponding genome type. The group studied included all cases younger than 2 years of age admitted to a seven crib ward in the Roberto del Rio Children's Hospital (Santiago, Chile) between May, 1995, and October, 1996. Nasopharyngeal aspirates for immunofluorescence assay and viral isolation were obtained on admission and the next day. On identification of a positive case for adenovirus, samples were obtained from contacts for 2 consecutive days and twice weekly thereafter for 2 weeks.
RESULTS: Fifteen index positive cases for adenovirus and their 65 contacts were identified. Secondary attack rate for adenoviral cross-infection was 55%, most of which were diagnosed by viral isolation. Mortality occurred in 4 cases; 3 had underlying diseases. Four secondary cases presented mild respiratory infection after acquiring the cross-infection, and 16 patients developed a moderate and severe ALRI. Twelve patients required supplemental oxygen and 4 needed mechanical respiratory support. Genome types for the 10 index cases and 19 contacts were obtained. All of these corresponded to adenovirus 7h.
CONCLUSIONS: The high secondary attack rate observed, stresses the importance of adequate isolation of patients and the need for rapid and sensitive viral diagnosis.

Entities:  

Mesh:

Year:  2000        PMID: 10877167     DOI: 10.1097/00006454-200006000-00007

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

1.  Respiratory syncytial virus, adenoviruses, and mixed acute lower respiratory infections in children in a developing country.

Authors:  Carlos E Rodríguez-Martínez; Diego Andrés Rodríguez; Gustavo Nino
Journal:  J Med Virol       Date:  2015-02-03       Impact factor: 2.327

2.  Necrotizing adenoviral pneumonia: manifestation of nosocomial infection in pediatric intensive care unit.

Authors:  Pradeep Vaideeswar; S B Bavdekar; Sandhya M Jadhav; Rajiv Balan; Shobhana P Pandit
Journal:  Indian J Pediatr       Date:  2008-09-22       Impact factor: 1.967

3.  Surveillance for respiratory syncytial virus in infants hospitalized for acute lower respiratory infection in Chile (1989 to 2000).

Authors:  Luis F Avendaño; María Angélica Palomino; Carmen Larrañaga
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

4.  Simulation of four respiratory viruses and inference of epidemiological parameters.

Authors:  Julia Reis; Jeffrey Shaman
Journal:  Infect Dis Model       Date:  2018-03-19

5.  A molecular epidemiology survey of respiratory adenoviruses circulating in children residing in Southern Palestine.

Authors:  Lina Qurei; Donald Seto; Zaidoun Salah; Maysa Azzeh
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

Review 6.  Transmission routes of respiratory viruses among humans.

Authors:  Jasmin S Kutter; Monique I Spronken; Pieter L Fraaij; Ron Am Fouchier; Sander Herfst
Journal:  Curr Opin Virol       Date:  2018-01-17       Impact factor: 7.090

Review 7.  Infectious disease modeling and the dynamics of transmission.

Authors:  L A Real; R Biek
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

8.  Respiratory viruses in pediatric emergency department patients and their family members.

Authors:  Nelsa Matienzo; Mariam M Youssef; Devon Comito; Benjamin Lane; Chanel Ligon; Haruka Morita; Arianna Winchester; Mary E Decker; Peter Dayan; Bo Shopsin; Jeffrey Shaman
Journal:  Influenza Other Respir Viruses       Date:  2020-07-30       Impact factor: 4.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.